An emerging consensus about treatment of the tiniest babies

IF 2.9 3区 医学 Q1 PEDIATRICS
Seminars in Fetal & Neonatal Medicine Pub Date : 2026-04-01 Epub Date: 2026-02-27 DOI:10.1016/j.siny.2026.101712
John D. Lantos
{"title":"An emerging consensus about treatment of the tiniest babies","authors":"John D. Lantos","doi":"10.1016/j.siny.2026.101712","DOIUrl":null,"url":null,"abstract":"<div><div>Over the past three decades, a broad consensus has emerged that decisions about life-sustaining treatment for extremely premature infants should be grounded in shared decision-making (SDM) between clinicians and parents. This consensus is endorsed by professional societies, bioethics commissions, and parents of babies in the neonatal intensive care unit. Despite this robust consensus, there is evidence that SDM is not always practiced. The evidence comes from observations of actual studies in which there is substantial practice variation that seems unlikely to reflect individualized decisions. In this paper, I examine the sources of that variation and argue that current SDM frameworks rest on an overly simplistic assumption that outcomes are stable, objective, unambiguous, and communicated clearly. In reality, prognostic data for survival and neurodevelopmental impairment are deeply contingent on treatment practices, prenatal management, institutional culture, and reporting conventions. These ambiguities complicate counseling, obscure value-laden judgments, and contribute to moral distress among clinicians. Moreover, parental preferences are heterogeneous and often reflect attitudes about disabilities that are different from the attitudes of health professionals. I propose a more dynamic model of SDM that acknowledges emotional complexity, evolving prognostic clarity, and the need for iterative decision-making over time. Rather than centering decisions on a single variable such as gestational age, this approach emphasizes individualized assessment, a trial of therapy when appropriate, and longitudinal conversations grounded in trust, empathy, and responsiveness to changing clinical realities. As neonatology continues to push the boundaries of viability—and as emerging technologies reshape the therapeutic landscape—ethical deliberation must keep pace. Clinicians and parents alike must navigate persistent uncertainty with humility, attentiveness to suffering, and a shared commitment to doing what is best for each infant and family.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"31 2","pages":"Article 101712"},"PeriodicalIF":2.9000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Fetal & Neonatal Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1744165X26000144","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Over the past three decades, a broad consensus has emerged that decisions about life-sustaining treatment for extremely premature infants should be grounded in shared decision-making (SDM) between clinicians and parents. This consensus is endorsed by professional societies, bioethics commissions, and parents of babies in the neonatal intensive care unit. Despite this robust consensus, there is evidence that SDM is not always practiced. The evidence comes from observations of actual studies in which there is substantial practice variation that seems unlikely to reflect individualized decisions. In this paper, I examine the sources of that variation and argue that current SDM frameworks rest on an overly simplistic assumption that outcomes are stable, objective, unambiguous, and communicated clearly. In reality, prognostic data for survival and neurodevelopmental impairment are deeply contingent on treatment practices, prenatal management, institutional culture, and reporting conventions. These ambiguities complicate counseling, obscure value-laden judgments, and contribute to moral distress among clinicians. Moreover, parental preferences are heterogeneous and often reflect attitudes about disabilities that are different from the attitudes of health professionals. I propose a more dynamic model of SDM that acknowledges emotional complexity, evolving prognostic clarity, and the need for iterative decision-making over time. Rather than centering decisions on a single variable such as gestational age, this approach emphasizes individualized assessment, a trial of therapy when appropriate, and longitudinal conversations grounded in trust, empathy, and responsiveness to changing clinical realities. As neonatology continues to push the boundaries of viability—and as emerging technologies reshape the therapeutic landscape—ethical deliberation must keep pace. Clinicians and parents alike must navigate persistent uncertainty with humility, attentiveness to suffering, and a shared commitment to doing what is best for each infant and family.
关于如何对待最小婴儿的共识正在形成。
在过去的三十年里,一个广泛的共识已经出现,关于极端早产儿的生命维持治疗的决定应该建立在临床医生和父母之间的共同决策(SDM)的基础上。这一共识得到了专业协会、生物伦理委员会和新生儿重症监护病房婴儿父母的认可。尽管有这种强有力的共识,但有证据表明SDM并不总是被实践。证据来自实际研究的观察,其中有大量的实践变化,似乎不太可能反映个性化的决定。在本文中,我检查了这种变化的来源,并认为当前的SDM框架建立在一个过于简单的假设上,即结果是稳定的、客观的、明确的、清晰的。实际上,生存和神经发育障碍的预后数据在很大程度上取决于治疗实践、产前管理、机构文化和报告惯例。这些模棱两可使咨询复杂化,模糊了价值判断,并导致临床医生的道德困扰。此外,父母的偏好是不同的,往往反映出对残疾的态度与卫生专业人员的态度不同。我提出了一个更动态的SDM模型,它承认情感的复杂性,不断发展的预测清晰度,以及随着时间的推移迭代决策的需要。这种方法不是将决策集中在胎龄等单一变量上,而是强调个性化评估,在适当的时候进行治疗试验,以及基于信任、同理心和对不断变化的临床现实的反应的纵向对话。随着新生儿科不断突破生存能力的界限,随着新兴技术重塑治疗领域,伦理审议必须跟上步伐。临床医生和父母都必须以谦卑的态度、对痛苦的关注和共同的承诺来应对持续的不确定性,为每个婴儿和家庭做最好的事情。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.40
自引率
3.30%
发文量
49
审稿时长
6-12 weeks
期刊介绍: Seminars in Fetal & Neonatal Medicine (formerly Seminars in Neonatology) is a bi-monthly journal which publishes topic-based issues, including current ''Hot Topics'' on the latest advances in fetal and neonatal medicine. The Journal is of interest to obstetricians and maternal-fetal medicine specialists. The Journal commissions review-based content covering current clinical opinion on the care and treatment of the pregnant patient and the neonate and draws on the necessary specialist knowledge, including that of the pediatric pulmonologist, the pediatric infectious disease specialist, the surgeon, as well as the general pediatrician and obstetrician. Each topic-based issue is edited by an authority in their field and contains 8-10 articles. Seminars in Fetal & Neonatal Medicine provides: • Coverage of major developments in neonatal care; • Value to practising neonatologists, consultant and trainee pediatricians, obstetricians, midwives and fetal medicine specialists wishing to extend their knowledge in this field; • Up-to-date information in an attractive and relevant format.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书